Heart News and Research

RSS

Emergency responses greatly increase risk to firefighters for heart disease

Firefighters engage in a dangerous occupation, risking life-threatening burns and smoke inhalation, among other hazards. So it may surprise some that the leading cause of death on duty among U.S. firefighters is coronary heart disease (CHD).

22 Mar 2007

FDA approves Soliris (eculizumab), first treatment for paroxysmal nocturnal hemoglobinuria

The U.S. Food and Drug Administration (FDA) has approved Soliris (eculizumab), the first product for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare type of blood disorder that can lead to disability and premature death.

19 Mar 2007

Blood pressure drug shows potential as lung cancer treatment

A hormone that is important in the control of blood pressure also shrinks lung cancer tumors in mice, suggesting a new way to prevent or treat the deadly cancer, according to scientists at Wake Forest University School of Medicine.

19 Mar 2007

Tykerb (lapatinib) - new anti-cancer treatment approved

The Food and Drug Administration (FDA) has approved Tykerb (lapatinib), a new targeted anti-cancer treatment, to be used in combination with capectabine (Xeloda), another cancer drug, for patients with advanced, metastatic breast cancer that is HER2 positive (tumors that exhibit HER2 protein).

14 Mar 2007

Chemical cues turn embryonic stem cells into cerebellar neurons

Embryonic stem cells have shown a great deal of promise for alleviating heart disease and regenerating organs. But for some of the conditions for which people hold out the most hope - Alzheimer's and Parkinson's, for example - there's been little evidence to date that stem cells can work.

14 Mar 2007

Crocodiles provide clues to new pain treatments for humans

Sydney University researchers have identified how crocodiles and other reptiles detect temperature - shedding new light on their adaptation to environmental changes and pointing to new pain treatments for humans.

14 Mar 2007

Talk therapy works for panic disorder

Psychoanalytic therapies have been in professional use for over a century, but a new study from physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center is the first to show that a classic psychoanalytic talk therapy is efficacious in treating panic disorder.

14 Mar 2007

Study aims to find which breast cancer patients need chemotherapy

Most postmenopausal women with small breast tumors don't need chemotherapy to reduce their recurrence risk after lumpectomy.

13 Mar 2007

Obese patients have a significantly higher risk of complications following surgery

The study, appearing in the March issue of the World Journal of Surgery, also found that morbidly obese patients had a death rate nearly twice as high as that of all other patients, as well as a higher rate of cardiac arrest.

13 Mar 2007

HIV in late childhood and adolescence a growing problem

Scientists have highlighted for the first time the plight of the growing number of older children and adolescents living with undiagnosed HIV and AIDS in Africa. In a study published today in Clinical Infectious Diseases, Wellcome Trust researchers claim that delay in recognising this problem means that the needs of this important group are not being met.

12 Mar 2007

A food supplement that could prevent the development of diabetes and atherosclerosis

The health benefits of cutting down on dietary saturated fatty acids and including higher levels of unsaturated fatty acids are well documented. Nutritional research is focusing on the effects of incorporating these healthier fatty acids, such as conjugated linoleic acid (CLA), into animal and human diets. CLA is present in dairy products and meat from ruminants and in very low amounts in our bodies.

11 Mar 2007

FDA strengthens safety information for Erythropoiesis-Stimulating Agents (ESAs)

The U.S. Food and Drug Administration (FDA) has issued a public health advisory outlining new safety information, including revised product labeling about erythropoiesis-stimulating agents (ESAs), widely-used drugs for the treatment of anemia.

11 Mar 2007

Kidney disease in children: common but treatable

"Kidney disease occurs more often than we think, but it is also more treatable than we used to think, especially when caught early," says Barbara Fivush, M.D., director of nephrology at the Johns Hopkins Children's Center.

8 Mar 2007

Quick diagnosis test for streptococcal strains

A streptococcal infection may initially cause nothing more than a relatively harmless sore throat. It can, however, also lead to potentially fatal disease or lifelong disability.

8 Mar 2007

Computer key unlocks cancer, multiple sclerosis, and Alzheimer's disease

Danish and Belgian researchers have found a computer key that maps genes underlying heritable disorders, such as breast cancer, multiple sclerosis, and Alzheimer's disease. These results will possibly ease the discovery of new medicines and improve treatment in various disorders.

8 Mar 2007

Lipitor given the green light for more heart risk patients

The Food and Drug Administration (FDA) in the U.S. has given approval for the best seller drug Lipitor to be used in five new categories.

8 Mar 2007

Tekturna new hypertension drug - first in a decade

The Food and Drug Administration (FDA) in the United States has given it's approval for the use of a new drug to treat hypertension.

7 Mar 2007

Inhaled Celecoxib shows new promise for lung cancer treatment

In recent years, Cycloxygenase (COX)-2 has emerged as a therapeutic target for the prevention and treatment of various types of cancers.

6 Mar 2007

Digital network links cardiovascular research globally

With $8.5 million in federal support, leading researchers at three universities, including Johns Hopkins, are creating an ambitious digital network that will allow cardiovascular researchers worldwide to easily exchange data and expertise on heart-related illnesses.

6 Mar 2007

FDA approves Tekturna for the treatment of high blood pressure

The U.S. Food and Drug Administration (FDA) today announced the approval of Tekturna (aliskiren) tablets for the treatment of high blood pressure, or hypertension, which affects an estimated 25 percent of Americans and causes increased risk of stroke, heart attack, kidney failure, heart failure and death.

6 Mar 2007